Africa’s vaccination campaign threatened as India suspends AstraZeneca exports

Africa’s vaccination campaign threatened as India suspends AstraZeneca exports
Written by Rey Jeremiah

The suspension by India came as the European Union met on Thursday to consider giving member states greater scope to block vaccines being exported outside the bloc, much of which is struggling to bring infections down and ramp up immunisation campaigns.

It is not known how long the suspension will last, but health watchers say the development is likely to delay the delivery of the nation’s 2nd batch of vaccine supplies expected around the end of March and early April.

READ ALSO:  2023: My successor will not be older than me - Umahi

The suspension could also  delay supplies to other African countries as well as several low and middle-income  countries  that are relying on India’s  production and supply of Covishield, its own version of the AstraZeneca vaccine,   manufactured under licence from AstraZeneca of the UK.

- Advertisment -

It was gathered that the suspension  would apply to all vaccines including the AstraZeneca shot on which the EU had originally been relying to meet a goal of inoculating 70 percent of its adult population.

READ ALSO:  Chinese company polluting water supply in FCT were not granted mining lease - FCT Minister

AstraZeneca’s vaccine is seen as crucial in tackling the pandemic as it is cheaper and easier to transport than rival shots.

The EU has accused the AstraZeneca drugmaker of over-selling its vaccine and unfairly favouring Britain, – a charge denied by the company.

- Advertisement -

Under the COVAX Facility sharing scheme backed by the World Health Organisation, Nigeria was allocated 16 million doses of the AstraZeneca vaccine  out of which it received 3.92 million doses in the first allocation.

- Advertisement -

About the author

Rey Jeremiah

Leave a Reply